The View on GU | with Lalani and Wallis
Episodes
Episode 37: ASCO GU 2026 Commentary: Kidney Cancer
06 Mar 2026
Contributed by Lukas
Dr. Aly-Khan Lalani and Dr. Christopher Wallis also discuss the RAMPART trial, LITESPARK-011, and the K-COMPASS model. This final recap episode highli...
Episode 36: ASCO GU 2026 Commentary: Bladder Cancer
06 Mar 2026
Contributed by Lukas
Dr. Aly-Khan Lalani and Dr. Christopher Wallis discuss practice-changing data in non-muscle invasive and muscle-invasive bladder cancer, including per...
Episode 35: ASCO GU 2026 Commentary: Prostate Cancer
06 Mar 2026
Contributed by Lukas
Dr. Aly-Khan Lalani and Dr. Christopher Wallis also highlight Canadian-led innovation in the GUNS trial and early data from the PAnTHA study, and disc...
Episode 34: The Business of Medical Entrepreneurship with Dr. Neil Fleshner
19 Jan 2026
Contributed by Lukas
In Episode 34, Dr. Aly-Khan Lalani and Dr. Christopher Wallis sit down with Dr. Fleshner to explore how an academic surgeon transitioned from traditio...
Episode 33: How Mentorship Shapes Medicine with Dr. Daniel Heng
18 Dec 2025
Contributed by Lukas
In Episode 33, Dr. Aly-Khan Lalani and Dr. Christoper Wallis sit down with Dr. Daniel Heng, Clinical Professor at the University of Calgary and Head o...
Episode 32: ESMO 2025 Commentary: Kidney Cancer
29 Oct 2025
Contributed by Lukas
Wrapping up our live ESMO 2025 coverage from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review pivotal kidney cancer data, includ...
Episode 31: ESMO 2025 Commentary: Prostate Cancer
29 Oct 2025
Contributed by Lukas
Live from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review the major ESMO 2025 prostate cancer studies, including ENZARAD, EMBAR...
Episode 30: ESMO 2025 Commentary: Bladder Cancer
29 Oct 2025
Contributed by Lukas
Live from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review ESMO 2025’s bladder cancer headlines, from the evolving role of PD-...
Episode 29: What’s Coming at ESMO 2025: A Preview with Dr. Monty Pal
14 Oct 2025
Contributed by Lukas
Ahead of ESMO 2025 in Germany, Dr. Monty Pal sits down with Dr. Aly-Khan Lalani and Dr. Chris Wallis to discuss what the oncology community can expect...
Episode 28: Inside Canada’s Drug Approval Process with Sudha Kutty of CDA-AMC (Part 1)
01 Oct 2025
Contributed by Lukas
Dr. Aly-Khan Lalani and Dr. Christopher Wallis sit down with the Executive Vice-President, Evidence, Products, and Services at Canada’s Drug Agency ...
Episode 27: Reimagining Prostate Cancer Imaging with Dr. Adam Kinnaird
07 Aug 2025
Contributed by Lukas
Dr. Adam Kinnaird of the University of Alberta joins Dr. Aly-Khan Lalani and Dr. Christopher Wallis to explore the evolution of prostate cancer diagno...
Episode 26: Real-World Evidence and the Future of Cancer Care with Dr. Winson Cheung
07 Jul 2025
Contributed by Lukas
From defining what real-world evidence is to discussing its impact on cancer drug approvals, comparative effectiveness, and synthetic data, Dr. Winson...
Episode 25: ASCO Annual Meeting 2025 Commentary: Bladder Cancer
07 Jun 2025
Contributed by Lukas
Concluding their three-episode series filmed live in Chicago, your hosts wrap up the weekend with a discussion of the key bladder cancer presentations...
Episode 24: ASCO Annual Meeting 2025 Commentary: Prostate Cancer
06 Jun 2025
Contributed by Lukas
Picking up from Episode 23, your hosts turn their focus to the highly anticipated prostate cancer presentations from the 2025 ASCO Annual Meeting in C...
Episode 23: ASCO Annual Meeting 2025 Commentary: Kidney Cancer
05 Jun 2025
Contributed by Lukas
Recorded live in Chicago, your hosts explore the latest in kidney cancer, discussing new five-year follow-up data from KEYNOTE-564, the long-term resu...
Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025
30 Apr 2025
Contributed by Lukas
With new bladder cancer therapies on the horizon, Dr. Lalani and Dr. Wallis review promising trial results - including EVER, CREST and the CISTO Study...
Episode 21: Prostate Cancer Imaging: When, Why and How? with Dr. Frédéric Pouliot
24 Apr 2025
Contributed by Lukas
In this informative episode, Dr. Aly-Khan Lalani and Dr. Christopher Wallis are joined by Dr. Frédéric Pouilot, a urologist-oncologist and researche...
Episode 20: Rolling Out Radioligand Therapy
11 Apr 2025
Contributed by Lukas
In this must-listen episode, your hosts are joined by Dr. Zukotynski, a Professor of Medicine and Radiology at McMaster University and staff member at...
ASCO GU 2025 Commentary: Breaking down the latest in kidney cancer
20 Feb 2025
Contributed by Lukas
Episode 19 is the final part of a mini-series from the 2025 ASCO Genitourinary Cancers Symposium in San Francisco! After diving into prostate and blad...
ASCO GU 2025 Commentary: Spotlight on bladder cancer
19 Feb 2025
Contributed by Lukas
Dr. Aly-Khan Lalani and Dr. Christopher Wallis reflect on the 2025 ASCO Genitourinary Cancers Symposium, with a focus on bladder cancer. This is the s...
ASCO GU 2025 Commentary: Deep dive into prostate cancer
18 Feb 2025
Contributed by Lukas
Dr. Aly-Khan Lalani and Dr. Christopher Wallis discuss new findings, novel treatment approaches, and research surrounding prostate cancer from their t...
Episode 16: ESMO 2024 Commentary: Kidney Cancer
26 Sep 2024
Contributed by Lukas
Wrapping up their ESMO Congress 2024 coverage with a discussion of renal cancer, our hosts talk about what strategies work (or don’t) after frontlin...
Episode 15: ESMO 2024 Commentary: Bladder Cancer
24 Sep 2024
Contributed by Lukas
In the second episode of our ESMO Congress 2024 series, our hosts discuss both non-muscle invasive and muscle-invasive bladder cancer, along with othe...
Episode 14: ESMO 2024 Commentary: Prostate Cancer
23 Sep 2024
Contributed by Lukas
In the first episode of this three-part series focused on the presentations and findings from the ESMO Congress 2024, our hosts focus on mCSPC prostat...
Episode 13: Radiation for Prostate Cancer with Dr. Andrew Loblaw (Part 2)
16 Jul 2024
Contributed by Lukas
Building on Episode 12, which focused on primary treatment for prostate cancer, Drs. Loblaw, Lalani and Wallis move on to discuss post-op treatments, ...
Episode 12: Radiation for Prostate Cancer with Dr. Andrew Loblaw (Part 1)
10 Jul 2024
Contributed by Lukas
Dr. Andrew Loblaw (Radiation Oncologist (Sunnybrook Research Institute), Clinician Scientist, and dual Professor in the Department of Radiation Oncolo...
Episode 11: ASCO Annual Meeting 2024 Commentary: Prostate Cancer
06 Jun 2024
Contributed by Lukas
Dr. Lalani and Dr. Wallis cover the utility of metformin, quality of life analyses, and optimizing treatment approaches for resistant prostate cancer,...
Episode 10: ASCO Annual Meeting 2024 Commentary: Bladder Cancer
05 Jun 2024
Contributed by Lukas
Our hosts start by discussing the 901 trial before moving into a discussion about bladder preservation and the importance of being multi-disciplinary....
Episode 9: ASCO Annual Meeting 2024 Commentary: Kidney Cancer
05 Jun 2024
Contributed by Lukas
The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home...
Episode 8: Oncology trial design and statistics with Dr. Pavlos Msaouel
27 May 2024
Contributed by Lukas
Joined by MD Anderson Cancer Center clinician and scientist Dr. Pavlos Msaouel, Dr. Aly-Khan Lalani and Dr. Christopher Wallis discuss trial design an...
Episode 7: Does physician gender matter? Impact on surgical outcomes, patient care and more
08 May 2024
Contributed by Lukas
Episode 7 was filmed live in Niagara, Ontario at the 13th Annual Juravinski Cancer Centre and Walker Cancer Centre Uro-oncology Forum! Our hosts discu...
Episode 6: See you at the next meeting? The intersection of medicine and politics
23 Apr 2024
Contributed by Lukas
In Episode 6, Drs. Aly-Khan Lalani and Christopher Wallis are joined by The View on GU’s first guest Dr. Diana Magee to discuss why location matters...
Episode 5: Biochemical Recurrence in Prostate Cancer
25 Mar 2024
Contributed by Lukas
In Episode 5, Drs. Aly-Khan Lalani and Christopher Wallis discuss biochemical recurrence in prostate cancer, including what they’re seeing in the fi...
Episode 4: Putting Into Practice: GU24 Highlights
16 Feb 2024
Contributed by Lukas
After returning from the 2024 ASCO Genitourinary Cancers Symposium in San Francisco, our hosts Drs. Aly-Khan Lalani and Christopher Wallis share key t...
Episode 3: ASCO GU 2024 Commentary: Kidney Cancer
01 Feb 2024
Contributed by Lukas
Filmed live at #GU24, episode 3 of The View on GU features a discussion on survival data with adjuvant therapy for patients with resected kidney cance...
Episode 2: ASCO GU 2024 Commentary: Bladder Cancer
01 Feb 2024
Contributed by Lukas
Filmed live at #GU24, episode 2 of The View on GU examines late breaking data for patients with urothelial carcinoma. The View on GU with Lalani &a...
Episode 1: ASCO GU 2024 Commentary: Prostate Cancer
01 Feb 2024
Contributed by Lukas
Filmed live at #GU24, episode 1 of The View on GU dives into new and updated data and novel treatment approaches for patients with prostate cancer. T...
Episode 0: The Kickoff!
22 Jan 2024
Contributed by Lukas
A new podcast developed by clinicians for clinicians, focused on optimizing multi-disciplinary healthcare within the field of genitourinary cancers. ...